ABX PENTRA ML, Software Versions: V8.0.x and Below; V.9.0.1 and V9.0.2

FDA Device Recall #Z-0645-2013 — Class II — September 20, 2012

Recall Summary

Recall Number Z-0645-2013
Classification Class II — Moderate risk
Date Initiated September 20, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Horiba Instruments, Inc dba Horiba Medical
Location Irvine, CA
Product Type Devices
Quantity 10 units

Product Description

ABX PENTRA ML, Software Versions: V8.0.x and Below; V.9.0.1 and V9.0.2

Reason for Recall

Horiba Medical is recalling ABX PENTRA ML because they have confirmed an issue with the ABX PENTRA ML data management and validation system. An incorrect patient result is transmitted to the Laboratory Information System. This result is from a previous run of the same patient that is stored in the ML database. This issue occurs in a very rare sequence of specific events. The affected software

Distribution Pattern

Nationwide in the US, including the states of CA, MI, IN, FL, and GA. Center Recall Depth is Retail.

Lot / Code Information

Lot/Serial# PML0937

Other Recalls from Horiba Instruments, Inc dba Horiba Me...

Recall # Classification Product Date
Z-2286-2018 Class II ABX Pentra Micro ALBUMIN 2 CP, Serum/Plasma, RE... Apr 26, 2018
Z-0493-2018 Class II 10 ML REAGENT CUP, B1034626, SAP 1221034626 for... Nov 21, 2017
Z-0494-2018 Class II 15 ML REAGENT CUP, B1037307, SAP 1221037307 for... Nov 21, 2017
Z-0902-2015 Class II ABX PENTRA Reagent Container, Model No. B103730... Nov 13, 2014
Z-2692-2014 Class II ABX PENTRA Magnesium RTU Reagent, Part No. A11A... Aug 11, 2014

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.